Bioactive biomaterials

Jeffrey A. Hubbell

Research output: Contribution to journalArticle

431 Citations (Scopus)

Abstract

The most important advances in the field of biomaterials over the past few years have been in bioactive biomaterials. Materials have been developed to incorporate bioactivity through biological recognition, including incorporation of adhesion factors, polyanionic sites that mimic the electrostatics of biological regulatory polysaccharides, and cleavage sites for enzymes involved in cell migration. Materials have also been developed to be active in biological environments by undergoing phase changes in situ, including transformations from liquid precursors to solids and from soluble materials to materials that are immobilised on tissue surfaces.

Original languageEnglish
Pages (from-to)123-129
Number of pages7
JournalCurrent Opinion in Biotechnology
Volume10
Issue number2
DOIs
StatePublished - Apr 1 1999
Externally publishedYes

Fingerprint

Biocompatible Materials
Biomaterials
Static Electricity
Cell Movement
Polysaccharides
Enzymes
Bioactivity
Electrostatics
Adhesion
Tissue
Liquids

ASJC Scopus subject areas

  • Biotechnology

Cite this

Bioactive biomaterials. / Hubbell, Jeffrey A.

In: Current Opinion in Biotechnology, Vol. 10, No. 2, 01.04.1999, p. 123-129.

Research output: Contribution to journalArticle

Hubbell, Jeffrey A. / Bioactive biomaterials. In: Current Opinion in Biotechnology. 1999 ; Vol. 10, No. 2. pp. 123-129.
@article{935b40152e484e6eae989adebd6fa7ea,
title = "Bioactive biomaterials",
abstract = "The most important advances in the field of biomaterials over the past few years have been in bioactive biomaterials. Materials have been developed to incorporate bioactivity through biological recognition, including incorporation of adhesion factors, polyanionic sites that mimic the electrostatics of biological regulatory polysaccharides, and cleavage sites for enzymes involved in cell migration. Materials have also been developed to be active in biological environments by undergoing phase changes in situ, including transformations from liquid precursors to solids and from soluble materials to materials that are immobilised on tissue surfaces.",
author = "Hubbell, {Jeffrey A.}",
year = "1999",
month = "4",
day = "1",
doi = "10.1016/S0958-1669(99)80021-4",
language = "English",
volume = "10",
pages = "123--129",
journal = "Current Opinion in Biotechnology",
issn = "0958-1669",
publisher = "Elsevier Limited",
number = "2",

}

TY - JOUR

T1 - Bioactive biomaterials

AU - Hubbell, Jeffrey A.

PY - 1999/4/1

Y1 - 1999/4/1

N2 - The most important advances in the field of biomaterials over the past few years have been in bioactive biomaterials. Materials have been developed to incorporate bioactivity through biological recognition, including incorporation of adhesion factors, polyanionic sites that mimic the electrostatics of biological regulatory polysaccharides, and cleavage sites for enzymes involved in cell migration. Materials have also been developed to be active in biological environments by undergoing phase changes in situ, including transformations from liquid precursors to solids and from soluble materials to materials that are immobilised on tissue surfaces.

AB - The most important advances in the field of biomaterials over the past few years have been in bioactive biomaterials. Materials have been developed to incorporate bioactivity through biological recognition, including incorporation of adhesion factors, polyanionic sites that mimic the electrostatics of biological regulatory polysaccharides, and cleavage sites for enzymes involved in cell migration. Materials have also been developed to be active in biological environments by undergoing phase changes in situ, including transformations from liquid precursors to solids and from soluble materials to materials that are immobilised on tissue surfaces.

UR - http://www.scopus.com/inward/record.url?scp=0032994943&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0032994943&partnerID=8YFLogxK

U2 - 10.1016/S0958-1669(99)80021-4

DO - 10.1016/S0958-1669(99)80021-4

M3 - Article

C2 - 10209141

AN - SCOPUS:0032994943

VL - 10

SP - 123

EP - 129

JO - Current Opinion in Biotechnology

JF - Current Opinion in Biotechnology

SN - 0958-1669

IS - 2

ER -